Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies

Jie Hu; Pai Peng; Kai Wang; Bei-zhong Liu; Liang Fang; Fei-yang Luo; Ai-shun Jin; Ni Tang; Ai-long Huang

doi:10.1101/2021.01.22.427749

New Results

Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies

Jie Hu, Pai Peng, View ORCID ProfileKai Wang, Bei-zhong Liu, Liang Fang, Fei-yang Luo, Ai-shun Jin, View ORCID ProfileNi Tang, View ORCID ProfileAi-long Huang

doi: https://doi.org/10.1101/2021.01.22.427749

Jie Hu

1Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, the Second Affiliated Hospital, Chongqing Medical University, Chongqing, China